Veterinary Laboratories Agency, U.K. and Applied Biosystems to Commercialize New Avian Influenza and Newcastle Disease Detection Kits; New Avian influenza assays developed by VLA expected to expand upon the existing Applied Biosystems Avian Influenza A/H5 detection kits.

0 Comments | M2 Presswire, March, 2007

M2 PRESSWIRE-7 March 2007-Applied Biosystems: Veterinary Laboratories Agency, U.K. and Applied Biosystems to Commercialize New Avian Influenza and Newcastle Disease Detection Kits; New Avian influenza assays developed by VLA expected to expand upon the existing Applied Biosystems Avian Influenza A/H5 detection kits(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:07032007 LONDON - Applied Biosystems (NYSE: ABI), an Applera Corporation business, and the Veterinary Laboratories Agency (VLA), a UK government agency specializing in animal disease surveillance and veterinary research, today announced a strategic collaboration to manufacture and commercialize the VLA's molecular avian influenza and Newcastle disease environmental detection kits.

These kits are expected to...